We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Sekisui Diagnostics UK Ltd.

Download Mobile App




Robotic-Assisted Percutaneous Ablation System Allows Physicians to Treat Inoperable, Difficult-to-Reach Tumors

By HospiMedica International staff writers
Posted on 13 Sep 2023
Print article
Image: The Epione robotic platform has obtained CE mark approval for expanded use in treatment of lung tumors (Photo courtesy of Quantum Surgical)
Image: The Epione robotic platform has obtained CE mark approval for expanded use in treatment of lung tumors (Photo courtesy of Quantum Surgical)

A state-of-the-art surgical robotic platform provides physicians with the ability to treat hard-to-reach, inoperable tumors at an early stage, in the most simple and effective manner.

Quantum Surgical (Montpellier, France) has developed the Epione robotic platform specifically for the curative treatment of cancers and abdominal tumors, including those in the liver, kidneys, and pancreas. This system utilizes a robotic arm, a navigation system, and a camera for assisting in performing percutaneous ablation which is an alternative to traditional surgery that involves inserting a needle through the skin directly into the tumor to destroy it. Epione integrates every phase of a percutaneous ablation procedure, from planning and targeting to ablation and confirmation while relying on the expertise of the medical professional involved.

Quantum Surgical has gained CE mark approval for the expanded application of the Epione robotic platform to treat lung tumors. The approval was based on a clinical study that explored the feasibility and safety of robot-guided thermal destruction of lung metastases. Throughout the study, the Epione robot demonstrated consistent technical success and a strong safety record. It shows promise in improving the minimally invasive approach to treating small and difficult-to-access lung tumors. Lung cancer, with over 2 million new cases globally in 2020, including about 500,000 in Europe, remains the leading cause of cancer-related deaths. The recent CE mark approval will enable this innovative, focused, and minimally invasive treatment method to reach a broader patient population in Europe.

“With Epione, our goal is to provide patients with an effective, better targeted and minimally invasive treatment. While over 2 million new cases of lung cancer diagnosed each year worldwide, we are delighted that our technology can now be accessible to new patients in Europe” said Bertin Nahum, President and Co-founder of Quantum Surgical.

Related Links:
Quantum Surgical

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Silver Member
Wireless Mobile ECG Recorder
NR-1207-3/NR-1207-E
New
Autoclavable Camera System
Precision AC

Print article

Channels

Critical Care

view channel
Image: The Esprit BTK System has received FDA approval for arteries below the knee (Photo courtesy of Abbott)

First-Of-Its-Kind Dissolvable Stent to Improve Outcomes for Patients with Severe PAD

Peripheral artery disease (PAD) affects millions and presents serious health risks, particularly its severe form, chronic limb-threatening ischemia (CLTI). CLTI develops when arteries are blocked by plaque,... Read more

Patient Care

view channel
Image: The newly-launched solution can transform operating room scheduling and boost utilization rates (Photo courtesy of Fujitsu)

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization

An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The Quantra Hemostasis System has received US FDA special 510(k) clearance for use with its Quantra QStat Cartridge (Photo courtesy of HemoSonics)

Critical Bleeding Management System to Help Hospitals Further Standardize Viscoelastic Testing

Surgical procedures are often accompanied by significant blood loss and the subsequent high likelihood of the need for allogeneic blood transfusions. These transfusions, while critical, are linked to various... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.